ClinVar

Description

Variant summary: GCH1 c.671A>G (p.Lys224Arg) results in a conservative amino acid change located in the GTP cyclohydrolase I domain (IPR020602) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00039 in 248968 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in GCH1 causing GTP Cyclohydrolase I Deficiency (0.00039 vs 0.0011), allowing no conclusion about variant significance. In a cross-sectional review, c.671A>G has been reported in the literature as a compound heterozygous genotype in individuals with autosomal recessive DOPA responsive dystonia (DRD) and in individuals with autosomal dominant features of athetoid cerebral palsy, GTP-CH deficiency, DRD, Parkinson disease (PD) (example, PMID: 19332422, 8852666, 9667588, 12391354, 18044725, 23942198, 17044972, 30314816). However, due to the presence in control cohorts, the possibility of reduced penetrance cannot be excluded. These data indicate that the variant is very likely to be associated with disease. To our knowledge, no variant specific experimental evidence demonstrating an impact on protein function has been reported. Nine clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (P/LP, n=5; VUS, n=4). Based on the evidence outlined above, the variant was classified as pathogenic.